Clinical Trial Update: Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 12 to 15 Months of Age. [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Hib-MenCY-TT vaccine to a licensed Haemophilus influenzae type b conjugate vaccine in children aged 12 to 15 months, with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilus Influenzae Type Disease
• Meningococcal Disease

Drugs mentioned

• Hib-MenCY-TT vaccine (Haemophilus influenzae type b meningococcal serogroups C and Y tetanus toxoid conjugate vaccine)
• Licensed Hib conjugate vaccine (Haemophilus influenzae type b conjugate vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Haemophilus Influenzae Type b, Neisseria Meningitidis | Phase 3 | Status: COMPLETED | Results posted: 2012-07-20